- 期刊
Clinical Efficacy and Safety of Reduced-Dose Prasugrel versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
摘要
Objectives: This systematic review and meta-analysis of randomized controlled trials (RCTs) compared the clinical efficacy and safety of reduced-dose prasugrel (loading dose: 20 mg; daily maintenance dose: 3.75 mg) and clopidogrel in patients undergoing percutaneous coronary intervention (PCI). Methods: PubMed, Embase, and the Cochrane Library database were searched for relevant articles from inception to March 8, 2021. Only RCTs that compared the clinical efficacy and safety of reduced-dose prasugrel and clopidogrel treatment in adult patients undergoing PCI were included. The primary outcome was the risk of major cardiovascular events (MACEs). Results: Four RCTs involving 2464 patients were included. The overall risk of MACEs was 8.3% (102/1235) in the study group (reduced-dose prasugrel) and 9.8% (121/1229) in the control group (clopidogrel). No significant difference was observed in the risk of MACEs between the study and control groups (risk ratio: 0.84, 95% confidence interval: 0.65-1.08, I^2 = 0%). In addition, cardiovascular-related death, all-cause death, nonfatal myocardial infarction, nonfatal stroke, revascularization, and stent thrombosis did not differ significantly between the two groups. Apart from a higher risk of minor bleeding in the study group, reduced-dose prasugrel had a similar bleeding risk to clopidogrel. Conclusions: The clinical efficacy of reduced-dose prasugrel is comparable to that of clopidogrel; however, the risk of minor bleeding should be considered when prescribing this regimen for patients undergoing PCI.
延伸閱讀
- Hsieh, P. J. (2022). Meta-analysis: Large randomized controlled trials of SGLT2 inhibitors in heart failureClinical Trial Protocol: Effects of SGLT2 inhibitor on Major Adverse Cardiovascular Events at discharge of Acute Coronary Syndrome [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU202203824
- 廖盈謹、蘇淑芬（2015）。Effectiveness of Vascular Closure Devices for Transfemoral Percutaneous Coronary Interventions: A Meta-Analysis。榮總護理，32(3)，237-246。https://doi.org/10.6142/VGHN.32.3.237
- 胡明齊（2020）。Efficacy and Safety of Recruitment Maneuver for Reducing Postoperative Pulmonary Atelectasis in Patients Receiving Cardiothoracic Surgery: Systematic Review and Meta-Analysis〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-1607202000170100
- Hajsadeghi, S., Chitsazan, M., Chitsazan, M., Salehi, N., Amin, A., Bidokhti, A. A., Babaali, N., Bordbar, A., Hejrati, M., & Moghadami, S. (2016). Prasugrel Results in Higher Decrease in High-Sensitivity C-Reactive Protein Level in Patients Undergoing Percutaneous Coronary Intervention Comparing to Clopidogrel. Clinical Medicine Insights: Cardiology, 2016(), 149-155. https://doi.org/10.4137/CMC.S32804
- Pepine, C. J. (2013). Effects of Pharmacologic Therapy on Health-Related Quality of Life in Elderly Patients with Atrial Fibrillation: A Systematic Review of Randomized and Nonrandomized Trials. Clinical Medicine Insights: Cardiology, 2013(), 1-20. https://doi.org/10.4137/CMC.S10628